Can a Week-Long wellness retreat boost cancer recovery?
NCT ID NCT07398079
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This pilot study is testing whether a 7-day integrative oncology retreat called 'Via Shalva' is practical and helpful for women who have finished primary treatment for breast or gynecologic cancer. Thirty participants will either attend the retreat or receive usual follow-up care. Researchers will measure how well the study runs and look for early signs of improvement in quality of life, stress, and other health markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Integrative Cure Stay retreat (behavioral intervention)
- What this could lead to
- If successful, this could show that a short retreat combining complementary therapies and group support is a practical way to improve quality of life for cancer survivors.
- What could go wrong
- This is a very small pilot study (30 participants) focused on feasibility, not proof of benefit. Results may not apply to all survivors, and any improvements might be due to natural recovery or placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a new drug combo revive Immunotherapy's power against resistant tumors?